Skip to Main Content

Author Details

Michelle D Williams
The University of Texas M. D. Anderson Cancer Center
2001
229
50
PMIDPaper TitleJournal TitlePublished Year
37993289Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?Surgery2024
38009416Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer.Head Neck2024
37853958Sinonasal NUT carcinoma: A consecutive case series and systematic review.Head Neck2024
36762947Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF<sup>V600E</sup> Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study.Thyroid2023
37289450Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review.JAMA Oncol2023
37053016Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics.J Clin Invest2023
36856048Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma.Otolaryngol Head Neck Surg2023
36654656Multimodal optical imaging with real-time projection of cancer risk and biopsy guidance maps for early oral cancer diagnosis and treatment.J Biomed Opt2023
36721313Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia.Cancer Med2023
36511380Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer.Thyroid2023
36503246Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series.Thyroid2023
34375025Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma.Cancer Cytopathol2022
35677816Multifocal recurrence of pleomorphic adenoma of the lacrimal gland.Am J Ophthalmol Case Rep2022
35834240Evaluating the Rising Incidence of Thyroid Cancer and Thyroid Nodule Detection Modes: A Multinational, Multi-institutional Analysis.JAMA Otolaryngol Head Neck Surg2022
36335817Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions.Oral Oncol2022
35932620Primary and recurrent regional metastases for lateralized oral cavity squamous cell carcinoma.Surg Oncol2022
36204100Effectiveness of core needle biopsy in the diagnosis of thyroid lymphoma and anaplastic thyroid carcinoma: A systematic review and meta-analysis.Front Endocrinol (Lausanne)2022
36324592Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.Front Oncol2022
36283091Evaluating new treatments for anaplastic thyroid cancer.Expert Rev Anticancer Ther2022
35977347Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma.JCO Precis Oncol2022
34897468Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score.J Clin Endocrinol Metab2022
34817546Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid Neoplasms.JAMA Otolaryngol Head Neck Surg2022
32687943Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting.Hum Pathol2021
33599171Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma.Thyroid2021
33536187ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of <i>RET</i>, <i>VEGFR2</i>, and <i>IGFBP2</i>.Mol Cancer Ther2021
33925205Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis.Biomedicines2021
33559990Emerging Entities and New Diagnostic Markers for Head and Neck Soft Tissue and Bone Tumors.Adv Anat Pathol2021
34638434<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.Cancers (Basel)2021
34804623Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Clinicopathologic Analysis with Evaluation of the E-Cadherin/<i>β</i>-Catenin Complex and Associated Genetic Alterations.Case Rep Pathol2021
34249457<i>ATF4</i> loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma.Am J Cancer Res2021
34243865Preoperative Molecular Testing of Thyroid Nodules: Current Concepts.Neuroimaging Clin N Am2021
34209210Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients.Cancers (Basel)2021
34120183A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.J Clin Endocrinol Metab2021
34147031Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.J Clin Endocrinol Metab2021
33169506Neoadjuvant selpercatinib for advanced medullary thyroid cancer.Head Neck2021
33353436Disseminated ALK-positive histiocytosis with <i>KIF5B-ALK</i> fusion in an adult.Leuk Lymphoma2021
32946597Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies.Laryngoscope2021
31124563Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.J Natl Cancer Inst2020
31910118A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation Trials.Thyroid2020
33203661Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.J Immunother Cancer2020
33318169Deep learning extended depth-of-field microscope for fast and slide-free histology.Proc Natl Acad Sci U S A2020
32999894Algorithm to quantify nuclear features and confidence intervals for classification of oral neoplasia from high-resolution optical images.J Med Imaging (Bellingham)2020
32761153Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019.JAMA Oncol2020
32731232Pathology and Differential Diagnosis of Anterior Skull Base Tumours.Adv Otorhinolaryngol2020
32900256Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report.Immunotherapy2020
32867110Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell Carcinoma.Cancers (Basel)2020
31621979Prospective evaluation of oral premalignant lesions using a multimodal imaging system: a pilot study.Head Neck2020
30500291Data Set for the Reporting of Nodal Excisions and Neck Dissection Specimens for Head and Neck Tumors: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.Arch Pathol Lab Med2019
31734935Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms.Endocr Pathol2019
30172560Surgical margins in head and neck cancer: Intra- and postoperative considerations.Auris Nasus Larynx2019
  • 1 - 50 of 229

Recommended Authors

David Geffen School of Medicine University of California Los Angeles California USA.
Career Start Year 2016
Number of shared co-authors 3
Southern Illinois University School of Medicine
Career Start Year 2013
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 4
Western University
Career Start Year 2009
Number of shared co-authors 0
New York-Presbyterian Hospital-Weill Cornell Medical College
Career Start Year 2008
Number of shared co-authors 1
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 2
Royal Prince Alfred Hospital
Career Start Year 2007
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 6
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
University of Tokyo
Career Start Year 2005
Number of shared co-authors 4
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 2
Jewish General Hospital
Career Start Year 2004
Number of shared co-authors 1
University Health Network
Career Start Year 2004
Number of shared co-authors 10
Virginia Mason Hospital and Seattle Medical Center
Career Start Year 2003
Number of shared co-authors 9
Yale School of Medicine
Career Start Year 2003
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 6
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 15
University of Western Ontario
Career Start Year 2001
Number of shared co-authors 13
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 8
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 11
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 12
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 7
Hospital of the University of Pennsylvania
Career Start Year 1995
Number of shared co-authors 1
University of Chicago Pritzker School of Medicine
Career Start Year 1993
Number of shared co-authors 6
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 1991
Number of shared co-authors 2
University of Michigan ann arbor
Career Start Year 1989
Number of shared co-authors 22
Jewish General Hospital, McGill University
Career Start Year 1987
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 10
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 8

Collaborators

MD Anderson Cancer Center
Co-authored papers 36
The University of Texas MD Anderson Cancer Center
Co-authored papers 23
The University of Texas MD Anderson Cancer Center Houston
Co-authored papers 17
Woodland Hills Medical Center
Co-authored papers 12
The University of Texas MD Anderson Cancer Center
Co-authored papers 12
MD Anderson Cancer Center
Co-authored papers 11
The University of Texas MD Anderson Cancer Center
Co-authored papers 10
Co-authored papers 10
UT Southwestern Medical Center
Co-authored papers 9
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Charles University
Co-authored papers 7
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Icahn School of Medicine at Mount Sinai Hospital.
Co-authored papers 6
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 4
Moores Cancer Center, university of california san diego
Co-authored papers 4
Stanford University
Co-authored papers 4
University of Texas MD Anderson Cancer Center
Co-authored papers 4
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
The University of Texas MD Anderson Cancer Center
Co-authored papers 3
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Co-authored papers 3
National Cancer Institute
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Present address: Dxige Research Inc.
Co-authored papers 2
The Ohio State University College of Medicine and Comprehensive Cancer Center
Co-authored papers 2
Case Western Reserve University
Co-authored papers 2